首页 › 基金 › Castlefield Investment Partners LLP › BSX

Castlefield Investment Partners LLP 对 BSX 的持仓历史

BOSTON SCIENTIFIC CORP · 医疗保健

Castlefield Investment Partners LLP 在 Q3 2026 的 13F 申报中披露持有 BSX(BOSTON SCIENTIFIC CORP)67,559 股,市值约 US$2.9M,约占其申报组合的 1.92%,在其申报持仓中市值排名第 26 位。 Castlefield Investment Partners LLP 最近 4 个申报季度中有 4 个季度披露了 BSX 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)67.56K 股
申报持仓市值$2.95M
组合权重1.92%
首次申报Q4 2025
最近变动增持
更新于2026-11-12

最后更新: 2026-11-12 · 来源: SEC EDGAR Form 13F-HR

Castlefield Investment Partners LLP 对 BSX 的持仓演变

Castlefield Investment Partners LLP 于 Q4 2025 首次披露 BSX 持仓:47,626 股(约 US$4.5M)。 在 4 次申报中,Castlefield Investment Partners LLP 3 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 67,559 股、市值约 US$2.9M,环比增持 10,652 股。。

逐季持仓明细

季度股数金额变化
Q4 2025 47.63K $4.54M 新进
Q1 2026 53.86K $3.38M 增持
Q2 2026 56.91K $2.43M 增持
Q3 2026 67.56K $2.95M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 BSX 与 13F 数据

BSX(BOSTON SCIENTIFIC CORP)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 BSX,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), 德劭基金 (US$1.16B), 骏利亨德森集团 (US$1.04B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BSX 的基金

查看 BSX 的全部基金持有人 →

常见问题

How long has Castlefield Investment Partners LLP held BSX?

Castlefield Investment Partners LLP has disclosed BSX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Castlefield Investment Partners LLP's current position in BSX?

As of Q3 2026, Castlefield Investment Partners LLP holds 67.56K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $2.95M, representing 1.92% of its reported portfolio and ranking #26.

Has Castlefield Investment Partners LLP been buying or selling BSX?

In the latest 13F filing (Q3 2026), Castlefield Investment Partners LLP increased its position in BSX.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, 德劭基金, 骏利亨德森集团, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.